Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens.
Researchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor's growth.
Read more at Medical News Today.
Wednesday, July 21, 2010
Researchers Block Pathway That Performs Key Function In End-Stage Prostate Cancer
Labels:
Prostate Cancer Prevention
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment